caus
seriou
diseas
human
aim
studi
examin
effect
aurintricarboxyl
acid
ata
replic
explor
underli
mechan
method
measur
activ
ata
inhibit
cytopath
effect
cpe
cellbas
neutral
inhibit
virusinduc
cpe
assay
perform
effect
ata
confirm
use
plaqu
reduct
viral
yield
reduct
assay
time
addit
assay
perform
identifi
mechan
ata
activ
examin
effect
ata
follow
key
step
involv
viru
replic
translat
intern
ribosom
entri
site
ire
mediat
viral
polyprotein
ii
proteolyt
activ
viral
proteas
andor
iii
viral
rnadepend
rna
polymeras
rdrp
activ
result
studi
ata
found
potent
inhibitor
replic
antivir
neutral
assay
ata
exhibit
inhibitori
activ
plaqu
assay
demonstr
ata
inhibit
replic
ec
effect
concentr
plaqu
remov
mm
studi
mechan
action
reveal
ata
target
earli
stage
viral
life
cycl
viral
entri
ata
abl
inhibit
rdrp
activ
neither
iresmedi
translat
viral
polyprotein
viral
proteas
activ
affect
conclus
overal
find
studi
suggest
ata
abl
effect
inhibit
replic
interf
viral
polymeras
enterovirus
member
famili
picornavirida
serotyp
includ
polioviru
type
coxsackieviru
coxsackieviru
b
echoviru
enteroviru
among
enteroviru
strain
enteroviru
may
caus
asept
mening
encephalomyel
even
acut
flaccid
paralysi
similar
paralyt
poliomyel
also
caus
polioviru
infect
current
specif
antivir
agent
avail
treatment
enteroviru
consist
singlestrand
positivesens
rna
nt
upon
infect
intern
ribosom
entri
site
ire
element
untransl
region
utr
drive
translat
viral
processor
polyprotein
polyprotein
encod
nh
proteolyt
cleav
viral
proteas
form
variou
structur
nonstructur
viral
protein
mani
import
stage
viral
life
cycl
consid
potenti
molecular
target
develop
antivir
agent
virusencod
proteas
polymeras
promin
target
consider
antivir
drug
develop
success
develop
antivir
agent
sever
virus
includ
hiv
hepat
b
viru
hbv
establish
virusencod
proteas
polymeras
valid
drug
target
virus
group
polyanion
compound
includ
aurintricarboxyl
acid
ata
shown
effect
inhibit
sever
virus
cell
cultur
ata
report
inhibit
adsorpt
thu
block
replic
hiv
interf
interact
viral
envelop
glycoprotein
receptor
cell
surfac
ata
also
demonstr
inhibit
replic
sever
rna
virus
hiv
vesicular
stomat
viru
sar
coronaviru
sarscov
influenza
viru
recent
ata
report
replicas
inhibitor
hepat
c
viru
hcv
present
studi
examin
effect
ata
inhibit
replic
viru
result
indic
ata
mitig
cytopath
effect
cpe
vero
cell
addit
ata
inhibit
elong
activ
viral
rnadepend
rna
polymeras
rdrp
vero
cell
african
green
monkey
kidney
cell
atcc
access
grown
modifi
eagl
medium
mem
gibco
rhabdomyosarcoma
cell
rd
cell
atcc
access
cell
african
green
monkey
kidney
cell
atcc
grown
dulbecco
modifi
eagl
medium
dmem
media
supplement
fetal
bovin
serum
fb
gibco
uml
penicillin
streptomycin
mm
lglutamin
virus
provid
clinic
virolog
laboratori
chang
gung
memori
hospit
linkou
taiwan
virus
amplifi
use
rd
cell
viru
titr
determin
plaqu
assay
use
vero
cell
measur
potenti
ata
inhibit
cpe
enteroviru
strain
tissu
cultur
plate
seed
ml
rd
cellsml
dmem
fb
cell
incub
h
viru
tcid
tissu
cultur
infecti
dose
mix
differ
concentr
ata
ad
cell
h
viral
adsorpt
infect
cell
overlaid
ml
dmem
dmso
incub
h
end
incub
cell
fix
formaldehyd
stain
crystal
violet
describ
previous
concentr
requir
test
compound
reduc
cpe
viru
ic
determin
plaqu
assay
perform
plate
contain
confluent
vero
monolay
cell
cell
inocul
enteroviru
titr
pfu
per
well
cell
h
incub
infect
media
aspir
well
cover
ml
agar
overlay
medium
contain
variou
concentr
compound
incub
day
co
incub
end
incub
cell
fix
formaldehyd
stain
crystal
violet
describ
previous
concentr
requir
ata
reduc
number
plaqu
ec
determin
vero
cell
infect
multipl
infect
moi
variou
concentr
compound
ad
cell
cultur
media
h
cultur
media
cell
lysat
collect
follow
freezethaw
cycl
subject
viru
titrat
plaqueform
assay
describ
previous
time
addit
experi
vero
cell
infect
enteroviru
pfuwel
incub
medium
specifi
timepoint
infect
ata
ad
mm
h
postinfect
hpi
cell
rins
pb
remov
drug
cultur
medium
overlay
without
drug
appli
detect
viral
infect
plaqu
assay
utr
contain
utr
renilla
firefli
luciferas
gene
use
evalu
iresdepend
translat
bicistron
plasmid
transfect
rd
cell
cellswel
plate
optimem
medium
replac
medium
without
ata
treatment
h
posttransfect
h
cell
lysat
collect
analys
determin
renilla
rluc
firefli
fluc
luciferas
activ
use
dualluciferas
report
assay
promega
corp
madison
wi
usa
follow
manufactur
instruct
report
plasmid
harbour
renilla
luciferas
control
earli
enhancerpromot
region
cotransfect
vero
cell
cellswel
plate
optimem
medium
replac
medium
without
ata
treatment
h
posttransfect
h
cell
lysat
collect
analys
determin
rluc
activ
use
renilla
luciferas
assay
system
promega
corp
follow
manufactur
instruct
vivo
activ
assay
proteas
cell
seed
plate
cell
per
well
incub
overnight
transient
transfect
cell
cotransfect
follow
combin
plasmid
ii
iii
iv
v
pcmvgal
intern
control
cotransfect
express
vector
h
posttransfect
secret
alkalin
phosphatas
seap
activ
cultur
medium
measur
use
phosphalight
assay
kit
tropix
foster
citi
ca
usa
chemiluminesc
detect
use
topcount
micropl
scintil
luminesc
counter
packard
meriden
ct
usa
gift
j
fang
nation
taiwan
univers
taipei
taiwan
detect
viral
rna
cell
total
vero
cell
seed
plate
reach
confluenc
challeng
viru
moi
total
rna
extract
cell
use
trizol
reagent
invitrogen
carlsbad
ca
usa
follow
phenolchloroform
extract
isopropanol
precipit
inhibit
enteroviru
replic
viral
polymeras
jac
rna
pellet
wash
dri
dissolv
ml
rnasefre
water
rtpcr
amplif
carri
use
reverseit
one
step
kit
abgen
epsom
surrey
uk
pcr
use
follow
protocol
min
min
cycl
min
addit
min
elong
last
cycl
rtpcr
product
examin
electrophoresi
agaros
gel
load
ml
gel
well
sequenc
primer
use
rtpcr
follow
ggagatagggtggcaga
genom
posit
genom
posit
determin
express
polymeras
polymeras
elong
assay
perform
describ
previous
rna
polymeras
assay
perform
u
polymeras
mm
hepe
ph
mm
mm
mgcl
mm
zncl
mm
utp
mciml
p
utp
mm
dt
mm
poli
ra
primertempl
variou
concentr
ata
reaction
incub
min
stop
addit
edta
mm
aliquot
ml
quench
reaction
spot
onto
filter
paper
disc
whatman
dri
room
temperatur
disc
wash
three
time
min
dibas
sodium
phosphat
rins
absolut
ethanol
radioact
sampl
quantifi
ml
scintil
fluid
data
point
meanssd
triplic
determin
previous
shown
number
agent
inhibit
replic
studi
found
replic
also
inhibit
ata
antivir
neutral
test
vero
cell
seed
plate
lyse
h
infect
shown
vc
viru
control
column
figur
without
viru
infect
ata
caus
appar
cell
lysi
concentr
mm
row
figur
cell
treat
ata
variou
concentr
ata
show
effect
protect
lysi
vero
cell
dosedepend
manner
row
figur
experi
triplic
subsequ
effect
ata
confirm
use
plaqu
reduct
viral
yield
reduct
assay
plaqu
reduct
assay
vero
cell
infect
titr
pfu
per
well
cell
plate
viru
adsorpt
h
ata
ad
vero
cell
variou
concentr
hung
et
al
ata
dosedepend
reduc
number
pfu
figur
ec
ata
measur
use
plaqu
reduct
assay
mm
cc
cytotox
concentr
cell
viabil
inhibit
ata
vero
cell
mm
determin
mt
assay
data
shown
therefor
select
index
cc
ec
ata
rang
base
differ
assay
effect
ata
yield
viral
progeni
cell
also
assess
experi
vero
cell
infect
moi
accompani
treatment
ata
variou
concentr
hpi
viral
progeni
present
cell
cultur
media
cell
lysat
harvest
pool
analys
viral
titr
use
plaqu
assay
shown
figur
c
ata
treatment
substanti
reduc
titr
viral
progeni
produc
infect
cell
cell
treat
ata
mm
decreas
viral
yield
evid
declin
viral
yield
ata
appli
treat
virusinfect
cell
mm
respect
result
show
ata
could
effect
reduc
product
viral
progeni
cell
differ
ec
valu
differ
assay
note
may
due
fact
differ
infect
condit
moi
employ
differ
assay
understand
mechan
ata
activ
time
addit
experi
conduct
ata
mm
ad
vero
cell
differ
timepoint
h
viru
infect
viru
infect
h
viru
infect
respect
cultur
supernat
remov
determin
viru
yield
approxim
one
viral
replic
cycl
yield
viral
progeni
normal
base
vehicl
control
volum
dmso
ad
figur
upon
ata
treatment
viral
yield
cell
reduc
antivir
effect
ata
start
decreas
ata
ad
timepoint
cell
treat
mm
ata
similar
phenomenon
observ
therefor
ata
activ
promin
appli
earli
stage
replic
cycl
overal
time
addit
experi
indic
ata
exert
antivir
effect
earlier
event
viru
replic
cycl
viral
absorpt
stage
howev
exact
underli
mechan
inhibit
ata
need
clarif
studi
experiment
examin
effect
ata
follow
key
step
involv
viru
replic
translat
iresmedi
viral
polyprotein
ii
proteolyt
activ
viral
proteas
andor
iii
viral
rdrp
elong
activ
examin
ata
interfer
iresmedi
translat
bicistron
express
system
contain
ire
ie
utr
utra
ie
antisens
utr
employ
shown
upper
panel
figur
iresdirect
translat
initi
effici
would
reflect
ratio
rluc
fluc
level
bicistron
plasmid
transfect
rd
cell
cell
lysat
collect
hpi
analys
determin
rluc
fluc
activ
signific
decreas
iresmedi
translat
observ
presenc
ata
even
concentr
mm
figur
thu
result
indic
ata
affect
iresmedi
translat
examin
ata
interfer
effect
proteas
vero
cell
use
method
describ
previou
studi
cell
cotransfect
report
plasmid
harbour
renilla
luciferas
plasmid
encod
viral
proteas
control
plasmid
encod
inact
proteas
singl
point
mutant
shown
figur
b
decreas
renilla
luciferas
signal
cell
lysat
proteas
express
compar
inact
proteas
cell
treat
ata
concentr
mm
restor
report
signal
vero
cell
cotransfect
report
plasmid
express
plasmid
figur
indic
ata
inhibit
activ
viral
proteas
examin
ata
inhibit
viral
proteas
employ
mammalian
cellbas
revers
twohybrid
system
function
analysi
viral
proteas
activ
describ
previou
studi
shown
upper
panel
figur
c
proteolyt
activ
proteas
monitor
cell
cultur
system
base
revers
twohybrid
system
domain
separ
inhibit
enteroviru
replic
viral
polymeras
selfcleavag
fail
turn
seap
express
cell
contrast
coexpress
mut
gave
rise
high
level
seap
enzymat
activ
cultur
supernat
transfect
cell
background
level
seap
activ
detect
cultur
supernat
cell
coexpress
level
seap
activ
cultur
supernat
cell
coexpress
significantli
enhanc
treatment
known
proteas
inhibitor
show
assay
use
monitor
activ
proteas
inhibitor
increas
seap
activ
seen
even
transfect
cell
treat
ata
concentr
mm
figur
thu
ata
interfer
viral
proteas
activ
reveal
cellbas
proteas
activ
assay
examin
effect
ata
synthesi
rna
treat
virusinfect
cell
ata
viral
rna
cell
analys
use
rtpcr
shown
figur
rtpcr
product
detect
cell
harvest
hpi
band
correspond
rtpcr
product
becam
promin
cell
lysat
harvest
hpi
presenc
ata
mm
level
rtpcr
product
greatli
reduc
result
suggest
ata
slow
viral
rna
synthesi
earli
stage
singl
round
viral
replic
cell
examin
reduc
viral
rna
synthesi
upon
ata
treatment
due
abil
ata
inhibit
polymeras
rdrp
rdrp
enzymat
activ
measur
describ
detect
amount
plabel
uridin
monophosph
ump
incorpor
poli
u
rna
presenc
poli
templat
oligo
dt
primer
rate
ump
incorpor
recombin
rdrp
presenc
dmso
vehicl
use
dissolv
ata
employ
control
presenc
ata
ump
incorpor
rdrp
reaction
product
clearli
inhibit
figur
ata
ad
rdrp
reaction
concentr
mm
inhibit
observ
howev
ata
began
inhibit
rdrp
activ
mm
mm
ata
reduc
rdrp
elong
activ
almost
control
ic
estim
mm
thu
result
suggest
ata
inhibit
rdrp
encod
summari
ata
uniqu
compound
pleiotrop
effect
cellular
function
broadspectrum
antivir
activ
ata
summar
tabl
sever
previou
inhibit
enteroviru
replic
viral
polymeras
jac
studi
describ
ata
inhibitor
polymeras
addit
yap
et
al
report
mechan
bind
ata
rdrp
sarscov
positivestrand
rna
virus
molecular
dock
method
recent
chen
et
al
also
report
ata
replicas
inhibitor
hcv
result
studi
demonstr
ata
abl
effect
inhibit
replic
inhibit
elong
activ
virusencod
polymeras
rdrp
noteworthi
inhibit
ata
may
due
sole
rdrp
inhibit
investig
need
explor
ata
also
affect
viral
cellular
function
import
replic
overal
result
studi
prove
import
develop
potent
agent
work
support
nation
health
research
institut
nhri
taiwan
none
declar
